Literature DB >> 3486741

Propionibacterium avidum as the etiologic agent of splenic abscess.

W M Dunne, H A Kurschenbaum, W R Deshur, T H Dee, T G Samter, J E Williams, R J Zabransky.   

Abstract

Propionibacterium avidum was isolated from an intrasplenic abscess in a patient recovering from coronary artery bypass surgery. This organism has not previously been reported as an etiologic agent of splenic abscess nor has splenic abscess been described as a complication of coronary bypass surgery. This report emphasizes the potential pathogenicity of normal microbial flora following surgical manipulation.

Entities:  

Mesh:

Year:  1986        PMID: 3486741     DOI: 10.1016/0732-8893(86)90096-9

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  5 in total

Review 1.  Clinical and Biological Features of Cutibacterium (Formerly Propionibacterium) avidum, an Underrecognized Microorganism.

Authors:  Stéphane Corvec
Journal:  Clin Microbiol Rev       Date:  2018-05-30       Impact factor: 26.132

Review 2.  Clinical microbiology of coryneform bacteria.

Authors:  G Funke; A von Graevenitz; J E Clarridge; K A Bernard
Journal:  Clin Microbiol Rev       Date:  1997-01       Impact factor: 26.132

3.  Propionibacterium avidum: A Virulent Pathogen Causing Hip Periprosthetic Joint Infection.

Authors:  Yvonne Achermann; Jared Liu; Reinhard Zbinden; Patrick O Zingg; Alexia Anagnostopoulos; Emma Barnard; Reto Sutter; Huiying Li; Andrew McDowell; Annelies S Zinkernagel
Journal:  Clin Infect Dis       Date:  2018-01-06       Impact factor: 9.079

4.  Complete Genome Sequence of Propionibacterium avidum Strain 44067, Isolated from a Human Skin Abscess.

Authors:  Lilla Ordögh; Judit Hunyadkürti; Andrea Vörös; Balázs Horváth; Attila Szucs; Edit Urbán; Attila Kereszt; Eva Kondorosi; István Nagy
Journal:  Genome Announc       Date:  2013-06-27

5.  Splenic Abscess in the New Millennium: A Descriptive, Retrospective Case Series.

Authors:  Christopher Radcliffe; Zeyu Tang; Savanah D Gisriel; Matthew Grant
Journal:  Open Forum Infect Dis       Date:  2022-02-17       Impact factor: 3.835

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.